Discussing whether Congress is launching a political assault on the Fed, with CNBC's Hampton Pearson; Thomas Woods, Ludwig von Mises Institu...
Insight on the Bear Stearns verdict, with Thomas Ajamie, Ajamie LLP; Tom Curran, Peckar & Abramson; and CNBC's Michelle Caruso-Cabrera.
Wesfarmers said it is concerned about rising interest rates and sentiment. Greg Fraser, senior industrials analyst at Fat Prophets speaks to...
Gold could reach as high as $1200/oz, says Akhi Kamkolkar, head of futures at Halifax Investments, speaking to Gavin Thomas, MD & CEO of Kin...
There is no "for sale" sign on Kingsgate Consolidated, says its MD & CEO, Gavin Thomas. He tells CNBC's Karen Tso the company has a long way...
Expect a bounce in the dollar in the short term, says Ed Ponsi, president at FXeducator.com, speaking to Gavin Thomas, MD & CEO of Kingsgate...
Gold will head higher, says Matt Martin, institutional salesperson at Wilson HTM, speaking to Gavin Thomas, MD & CEO of Kingsgate Consolidat...
With payrolls shrinking in many sectors, benefits providers are under pressure. Thomas Watjen, CEO of Unum, discusses the challenges.
“We should be very happy with the way things have evolved,” Thomas Mirow, president of EBRD, told CNBC. Twenty years after the fall of the B...
New York City Health Commissioner Dr. Thomas Farley discusses seasonal flu shot shortages and why some banks have received the vaccination w...
James Paulsen, of Wells Capital Management; Thomas Lee, of JPMorgan; and Robert Barbera, of ITG, look ahead to the jobs report and discuss h...
Insight on what Buffett's move tells us about investing in America, with Thomas Russo, Gardner, Russo & Gardner and David Pearl, Epoch Inves...
Bank lending in China rose 20% on month in October. Peter Lai, director from DBS Vickers Securities assesses what this means for its economy...
Australia's growth in 2010 could outstrip that of the U.S., the EU and Japan, believes Thomas Byrne, senior VP, Asia-Middle East Sovereign a...
Countries need to grow in order to get out of a debt problem, says Thomas Byrne, senior VP, Asia-Middle East Sovereign at Moody's Sovereign ...
Human Genome and GlaxoSmithKline will seek FDA approval in the first half of next year for Lupus drug Benlista. CNBC's Mike Huckman discusse...
Discussing the state of the economy with Richard Bernstein, of Richard Bernstein Capital; Thomas McManus, of Wells Fargo; and CNBC's Steve L...
Making sense of Friday's selloff with John Ryding, of RDQ Economics; Thomas McManus, of Wells Fargo; and Rich Bernstein, of Richard Bernstei...
"We're definitely suffering a crisis in transition," Thomas Wieser, member of Austrian Ministry of Finance and EU Economic & Financial Commi...
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
